 | | Vol. 12.04 – 4 February, 2021 |
| |
|
|
| In naive cells, the deletion of Foxo1 following thymic development resulted in the increased expression of multiple AP-1 family members, rendering T cells less able to respond to antigenic challenge.
[Cell Reports] |
|
 |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers analyzed the transcriptomes and effector functions of cord blood innate lymphoid cells (ILCs). By RNAseq analysis, all ILC subsets could be clearly distinguished from each other.
[Stem Cells Translational Medicine] |
|
|
|
| In a Phase I/IIa trial, scientists evaluated the safety and possible clinical efficacy of intravenous infusion of allogeneic human umbilical cord blood–derived mesenchymal stem cells in patients with recessive dystrophic epidermolysis bullosa.
[JCI Insight] |
|
|
|
| Doxorubicin, a commonly used chemotherapy drug, was used to treat human umbilical cord-derived MSCs for six hours as an in vitro cell model of chemotherapy-induced damage.
[Stem Cell Research & Therapy] |
|
|
|
| Investigators compared clinical and second-look arthroscopic outcomes between bone marrow aspirate concentrate augmentation and human umbilical cord blood-derived mesenchymal stromal cell implantation in high tibial osteotomy for medial compartmental knee osteoarthritis.
[Knee Surgery, Sports Traumatology, Arthroscopy] |
|
|
|
| The differentiation of Wharton jelly (WJ)-MSCs into Schwann cell-like cells was determined by analyzing Schwann cell-specific markers. The secretion of neurotrophic factors was assessed by the Neuro Discovery antibody array.
[Tissue Engineering and Regenerative Medicine] |
|
|
|
|
| The authors describe the biological characteristics and advantages of human amnion-derived stem cells, especially for their high pluripotency and immunomodulatory effects.
[International Journal of Molecular Sciences] |
|
|
|
|
| Sorrento Therapeutics, Inc.  announced additional positive results from its Phase Ib study of human allogeneic adipose-derived mesenchymal stem cells for patients suffering from COVID-19-induced acute respiratory distress or acute respiratory distress syndrome.
[Sorrento Therapeutics, Inc. ] |
|
|
|
|
| March 14 – 17, 2021
Virtual |
|
|
|
|
|
| | University of Oxford – Oxford, England, United Kingdom |
|
|
|
| | St. Jude Children’s Research Hospital – Memphis, Tennessee, United States |
|
|
|
| | The Jackson Laboratory – Bar Harbor, Maine, United States |
|
|
|
| | Blood Research Institute – Milwaukee, Wisconsin, United States |
|
|
|
| | St. Jude Children’s Hospital – Memphis, Tennessee, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
